Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Lupin Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (288)
ARTG (239)
Prescription medicine registration (18)

Date

2024 (48)
2023 (47)
2022 (222)
2021 (8)
2020 (33)
2019 (21)
2018 (32)
2017 (11)
2016 (10)
2014 (27)
2013 (17)
2012 (2)
2011 (16)
2010 (19)
2009 (1)
2008 (21)
2007 (5)
2001 (1)
1991 (4)

Results for "[search-keyword]"

Search

Sponsor content

545 result(s) found, displaying 71 to 80

TIOTROPIUM GH (Lupin Australia Pty Limited)

24 July 2023

Prescription medicine registration

Active ingredients: Tiotropium bromide monohydrate.
GLICLAZIDE GH MR gliclazide 60 mg modified release tablet blister pack (370852)

14 November 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for GLICLAZIDE GH MR gliclazide 60 mg modified release tablet blister pack.
GLICLAZIDE LUPIN MR gliclazide 60 mg modified release tablet blister pack (370851)

14 November 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for GLICLAZIDE LUPIN MR gliclazide 60 mg modified release tablet blister pack.
PREGABALIN GH pregabalin 25 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
LEVOTHYROXINE LAPL levothyroxine sodium 100 microgram tablet bottle pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
LEVOTHYROXINE LAPL levothyroxine sodium 50 microgram tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
LEVOTHYROXINE LAPL levothyroxine sodium 50 microgram tablet bottle pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
LEVOTHYROXINE LAPL levothyroxine sodium 200 microgram tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
LEVOTHYROXINE LAPL levothyroxine sodium 100 microgram tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
LEVOTHYROXINE LAPL levothyroxine sodium 200 microgram tablet bottle pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Lupin Australia Pty Limited

Pages

First page
Previous page
…
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Page 11
Page 12
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.